Back To Search Results

EMS Prehospital CPAP Devices

Editor: Scott Goldstein Updated: 6/22/2024 3:49:47 PM

Introduction

Noninvasive ventilation involves providing ventilatory support through the upper airway using a mask or similar device, avoiding the need for endotracheal intubation. This method minimizes complications such as ventilator-associated pneumonia and airway trauma associated with invasive methods. Noninvasive positive pressure ventilation (NIPPV) has become a standard intervention for respiratory distress in the prehospital setting.[1] During the 1950s polio epidemic, Bjorn Ibsen pioneered positive pressure ventilation, significantly reducing mortality rates.[2] By the 1980s, noninvasive forms of continuous positive airway pressure (CPAP) were adopted for obstructive sleep apnea and chronic obstructive pulmonary disease (COPD).[3][4]

Early NIPPV models used a control unit or flow generator attached to the oxygen source to produce the necessary positive pressure. Newer CPAP devices deliver a specific amount of pressure by either adjusting a control valve or the amount of flow supplied to produce the necessary positive end-expiratory pressure (PEEP). These newer models have all the necessary parts integrated into the device, costing much less compared to the original devices. Newer devices continue to decrease costs and improve simplicity.

Using CPAP in the prehospital setting gained traction in the late 1990s as the primary form of NIPPV and an alternative to endotracheal intubation or supraglottic devices. CPAP is the most commonly used NIPPV modality in the prehospital setting and helps improve the work of breathing and oxygenation for patients with different cardiopulmonary complaints. The use of prehospital NIPPV has reduced rates of intubation and complications such as hypotension, hypoxia, and cardiac arrest.[5][6] Over the past several years, this type of ventilation has become the standard of care for patients with acute respiratory distress in the prehospital setting. A meta-analysis performed by Goodacre et al shows a reduction in mortality and intubation rates compared to standard care.[7]

Anatomy and Physiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Anatomy and Physiology

NIPPV improves pulmonary function by enhancing lung compliance, recruiting and stabilizing alveoli, and reducing the work of breathing. NIPPV functions by applying PEEP and inspiratory positive airway pressure (IPAP). PEEP helps overcome intrinsic PEEP in conditions such as COPD, preventing alveolar collapse during exhalation and promoting better gas exchange.[8] With each breath, the negative intrathoracic pressure causes the alveoli and distal pulmonary structures to collapse. Still, in patients with COPD or pulmonary fibrosis, an abnormal residual pressure occurs due to air trapping, called auto-PEEP. CPAP applies constant pressure throughout the ventilation cycle, ultimately preventing the alveoli from collapsing entirely during exhalation.

Improved gas exchange also improves edema and recruitment.[9] This positive pressure reduces the surface tension on the walls of the alveoli by increasing the intrathoracic pressure, which helps to reduce the work of breathing. Similarly, an increase in alveolar surface area increases gas exchange. The increased intrathoracic pressure reduces preload and promotes a fluid shift out of the lungs and back into the pulmonary vasculature.[10]

Indications

Individuals who breathe spontaneously throughout the entire respiratory cycle can use NIPPV. The primary function of NIPPV is to improve pulmonary compliance and alveoli aeration by recruiting and stabilizing collapsed alveoli, improving ventilation-perfusion mismatches. CPAP increases intrathoracic pressure, reducing venous return (preload), transmural pressure, and afterload. These changes ultimately allow for enhancement in cardiac function and reduce pulmonary edema. The latest American Thoracic Society/European Respiratory Journal guidelines strongly support the use of noninvasive ventilation in acute exacerbations of COPD and acute respiratory failure secondary to cardiogenic pulmonary edema.[11][12][13]

Common indications for CPAP include:

  • Heart failure: NIPPV reduces the need for intubation and improves outcomes in patients with acute cardiogenic pulmonary edema by decreasing preload and afterload, alleviating pulmonary congestion.
  • Chronic pulmonary diseases, including COPD and asthma: Bilevel positive airway pressure (BiPAP) reduces the work of breathing and improves gas exchange, preventing respiratory failure progression. Although used less commonly, NIPPV can benefit severe asthmatic exacerbations by reducing air trapping and improving alveolar ventilation.
  • Acute bronchitis and pneumonia: In select cases, NIPPV supports patients with pneumonia by enhancing oxygenation and reducing breathing work, particularly in those with chronic lung disease.
  • Blunt chest wall trauma, including flail chest: NIPPV can be used in trauma patients with respiratory distress and without contraindications such as facial fractures or aspiration risks.
  • Toxic inhalation, such as chlorine
  • Severe obesity: NIPPV can remove some metabolic demands by decreasing the workload required to ventilate patients with obesity hypoventilation syndrome.
  • Near drownings
  • Neonates with respiratory distress
  • Patients with a do-not-resuscitate status secondary to advanced disease or terminal illnesses.[6][14][15]

Contraindications

Absolute contraindications for NIPPV include cardiac arrest, respiratory arrest, coma, or any condition requiring immediate intubation. In addition, facial burns or trauma, active vomiting, or a fixed airway obstruction are all contraindications to NIPPV. Relative contraindications for noninvasive, positive-pressure ventilation include: 

  • Poor clearance of secretions
  • Depressed sensorium and lethargy
  • Shock with the need for pressor support
  • Ventricular dysrhythmias
  • Intractable emesis
  • Uncontrollable bleeding
  • Status epilepticus
  • Potential for upper airway obstruction 
  • Anaphylaxis
  • Tracheal injuries
  • Maxillofacial or basilar skull fractures
  • External masses compressing the airway

Equipment

Modern CPAP devices are portable and cost-effective, incorporating a flow generator and a PEEP valve to maintain PEEP. For prehospital clinicians, multiple commercial-grade devices that combine the flow generator with the face mask as a disposable product are available. Standard settings typically range from 5 to 10 cm H2O. Patients with asthma, bronchitis, and COPD typically start with a pressure of 5 cm H2O versus those with heart failure, severe pneumonia, and pulmonary edema due to near-drownings at 10 cm H2O. At these levels, the work of breathing can be reduced by as much as 60% and improve inspiratory muscle endurance by up to 95%.[16][17][18]

Personnel

Implementing NIPPV in the prehospital setting requires comprehensive training for emergency medical service (EMS) personnel, appropriate equipment, and clear protocols. Personnel must be skilled in patient selection, mask fitting, and monitoring therapy effectiveness. The scope of practice for EMS clinicians over the years has changed with the 2018 National EMS Scope of Practice Model introduced by the National Highway Traffic Safety Administration, which further delineates the roles of prehospital clinicians. The original 2007 Practice Model for EMS clinicians had CPAP/BiPAP as a paramedic skill. Since the release of the 2018 National EMS Scope of Practice Model, EMT-Basics are now being trained in using CPAP in patient care. In many states, an EMT-B can use a CPAP device with appropriate training and approval from their medical director.[19] EMS clinicians should receive training in the indications, contraindications, and practical application of NIPPV, including troubleshooting common issues. Protocols should outline the criteria for initiating noninvasive ventilation, monitoring parameters, and steps for escalation of care if NIPPV fails.

Preparation

Patients who have never used an NIPPV device need education before application and may need help to ensure they do not fight the device. Full-face mask devices can induce claustrophobia in some patients. Education and coaching from clinicians are crucial for ensuring patient comfort. When treating a patient in acute respiratory distress, prehospital clinicians should assemble the NIPPV device quickly.

The device should be ensured to be attached to an adequately filled oxygen source because most devices use a large amount of oxygen. Specific manufacturers' device instructions should always be referred to.

Technique or Treatment

Before placing a CPAP mask, the patient is informed about how the mask will feel to anticipate any anxiety associated with wearing the device. The mask is then applied to the patient's face, and they are coached to take deep breaths. Care should be taken to ensure the mask is not too tight, which can cause discomfort and leaks. The head strap is applied to ensure the mask is comfortable and sealed against the patient's face. The patient is positioned in a semi-upright position to facilitate better breathing. 

  • CPAP: The device is started at a lower pressure setting, around 5 cm H2O, to allow for acclimation. Gradually, this pressure can be raised to 10 cm H2O. Some patients may benefit from higher CPAP. Oxygen can then be titrated based on SpO2, typically starting with 2 to 4 L/min.
  • BiPAP: the patient is started on lower pressures to allow for acclimatization. Typically, an IPAP of 10 cm H2O and an expiratory positive airway pressure of 5 cm H2O are used. The typical range for IPAP is 10 to 20 cm H2O, whereas expiratory positive airway pressure typically ranges from 4 to 10 cm H2O. Oxygen flow is adjusted, starting at 2 to 4 L/min, and titrated based on SpO2 readings.

The patient is reassessed frequently to improve their respiratory status, lung sounds, and tolerance of the device. The patient's vital signs, including respiratory rate, heart rate, blood pressure, and SpO2, are monitored regularly. The patient's clinical response is assessed, including improvement in breathlessness, reduction in respiratory rate, and stabilization of vital signs.

Complications

Complications of NIPPV include patient discomfort, anxiety, and agitation. More severe complications may consist of pulmonary barotrauma or hypotension secondary to increased intrathoracic pressure and reduced preload. Gastric distention may result in abdominal compartment syndrome; this is most likely to occur with an IPAP greater than 20 cm H2O.[20] Many of these problems can be alleviated using the lowest, safest setting that provides results. Hypotension can be treated with intravenous fluids.

Clinical Significance

Noninvasive positive pressure and CPAP ventilation significantly improve acute respiratory distress from several etiologies. NIPPV also decreases the rate of intubations and more invasive management, which may lead to subsequent aspiration, infections, and prolonged hospitalizations. NIPPV is the mainstay treatment for patients with heart failure and COPD. Ucgun et al demonstrated that the most important predictor of mortality in patients with COPD is invasive ventilation and complications related to mechanical ventilation; preventing invasive ventilation is essential.[12][21][22]

Recent meta-analyses and studies have demonstrated that prehospital noninvasive positive pressure ventilation (NIPPV) significantly enhances patient outcomes. Specifically, NIPPV has been shown to reduce mortality rates and decrease the necessity for intubation in patients.[7] Noninvasive ventilation, including CPAP and BiPAP, is a critical intervention for managing respiratory distress in the prehospital environment. Evidence supports the use in conditions such as heart failure, COPD, and potentially asthma and pneumonia. Effective implementation requires proper training, appropriate equipment, and well-defined protocols. Integrating NIPPV can significantly enhance patient outcomes and reduce emergency department burdens as EMS systems evolve.

Enhancing Healthcare Team Outcomes

Prehospital clinicians have been conducting research to demonstrate the efficacy of noninvasive ventilation in the prehospital setting. The research has been overwhelmingly positive, where the 2018 EMS Scope of Practice Model concludes using CPAP at the EMT level and above.

The EMS scope of practice model, along with the EMS agenda for the future, shows the value and need for prehospital clinicians to be educated to perform the skills, with most training programs being accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP), then certified as competent with most states requiring an initial certification through the National Registry of emergency medical technicians. Most states allow prehospital clinicians to perform noninvasive ventilation as a minimum scope of practice, with medical directors credentialling the prehospital clinicians. The trend for using noninvasive ventilation in the prehospital setting has influenced emergency medicine clinicians, nurses, respiratory therapists, and hospitals to adopt a similar practice method of using noninvasive ventilation in the hospital setting. Education on noninvasive ventilation has become a collegial endeavor between prehospital and hospital clinicians.

References


[1]

Walter DC, Chan HK, Crowe RP, Osborn L, Jarvis J, Wang HE. Out-of-hospital, non-invasive, positive-pressure ventilation for acute dyspnea. Journal of the American College of Emergency Physicians open. 2021 Dec:2(6):e12542. doi: 10.1002/emp2.12542. Epub 2021 Nov 4     [PubMed PMID: 34761248]


[2]

Kelly FE, Fong K, Hirsch N, Nolan JP. Intensive care medicine is 60 years old: the history and future of the intensive care unit. Clinical medicine (London, England). 2014 Aug:14(4):376-9. doi: 10.7861/clinmedicine.14-4-376. Epub     [PubMed PMID: 25099838]


[3]

Slutsky AS. History of Mechanical Ventilation. From Vesalius to Ventilator-induced Lung Injury. American journal of respiratory and critical care medicine. 2015 May 15:191(10):1106-15. doi: 10.1164/rccm.201503-0421PP. Epub     [PubMed PMID: 25844759]


[4]

LASSEN HC. A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency. Lancet (London, England). 1953 Jan 3:1(6749):37-41     [PubMed PMID: 13011944]


[5]

Meng M, Zhang J, Chen L, Wang L. Prehospital noninvasive positive pressure ventilation for severe respiratory distress in adult patients: An updated meta-analysis. Journal of clinical nursing. 2022 Dec:31(23-24):3327-3337. doi: 10.1111/jocn.16224. Epub 2022 Feb 24     [PubMed PMID: 35212078]

Level 1 (high-level) evidence

[6]

Abubacker AP, Ndakotsu A, Chawla HV, Iqbal A, Grewal A, Myneni R, Vivekanandan G, Khan S. Non-invasive Positive Pressure Ventilation for Acute Cardiogenic Pulmonary Edema and Chronic Obstructive Pulmonary Disease in Prehospital and Emergency Settings. Cureus. 2021 Jun:13(6):e15624. doi: 10.7759/cureus.15624. Epub 2021 Jun 13     [PubMed PMID: 34277241]


[7]

Goodacre S, Stevens JW, Pandor A, Poku E, Ren S, Cantrell A, Bounes V, Mas A, Payen D, Petrie D, Roessler MS, Weitz G, Ducros L, Plaisance P. Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2014 Sep:21(9):960-70. doi: 10.1111/acem.12466. Epub     [PubMed PMID: 25269576]

Level 1 (high-level) evidence

[8]

Popowicz P, Leonard K. Noninvasive Ventilation and Oxygenation Strategies. The Surgical clinics of North America. 2022 Feb:102(1):149-157. doi: 10.1016/j.suc.2021.09.012. Epub     [PubMed PMID: 34800383]


[9]

Laghlam D, Benghanem S, Ortuno S, Bouabdallaoui N, Manzo-Silberman S, Hamzaoui O, Aissaoui N. Management of cardiogenic shock: a narrative review. Annals of intensive care. 2024 Mar 30:14(1):45. doi: 10.1186/s13613-024-01260-y. Epub 2024 Mar 30     [PubMed PMID: 38553663]

Level 3 (low-level) evidence

[10]

Mosier JM, Tidswell M, Wang HE. Noninvasive respiratory support in the emergency department: Controversies and state-of-the-art recommendations. Journal of the American College of Emergency Physicians open. 2024 Apr:5(2):e13118. doi: 10.1002/emp2.13118. Epub 2024 Mar 7     [PubMed PMID: 38464331]


[11]

Williams JW Jr, Cox CE, Hargett CW, Gilstrap DL, Castillo CE, Govert JA, Lugogo NL, Coeytaux RR, McCrory DC, Hasselblad V, McBroom AJ, Posey R, Gray R, Sanders GD. Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure. 2012 Jul:():     [PubMed PMID: 22876372]


[12]

Pang D, Keenan SP, Cook DJ, Sibbald WJ. The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. Chest. 1998 Oct:114(4):1185-92     [PubMed PMID: 9792593]

Level 2 (mid-level) evidence

[13]

Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, Navalesi P Members Of The Steering Committee, Antonelli M, Brozek J, Conti G, Ferrer M, Guntupalli K, Jaber S, Keenan S, Mancebo J, Mehta S, Raoof S Members Of The Task Force. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. The European respiratory journal. 2017 Aug:50(2):. pii: 1602426. doi: 10.1183/13993003.02426-2016. Epub 2017 Aug 31     [PubMed PMID: 28860265]

Level 1 (high-level) evidence

[14]

Mukherjee K, Schubl SD, Tominaga G, Cantrell S, Kim B, Haines KL, Kaups KL, Barraco R, Staudenmayer K, Knowlton LM, Shiroff AM, Bauman ZM, Brooks SE, Kaafarani H, Crandall M, Nirula R, Agarwal SK Jr, Como JJ, Haut ER, Kasotakis G. Non-surgical management and analgesia strategies for older adults with multiple rib fractures: A systematic review, meta-analysis, and joint practice management guideline from the Eastern Association for the Surgery of Trauma and the Chest Wall Injury Society. The journal of trauma and acute care surgery. 2023 Mar 1:94(3):398-407. doi: 10.1097/TA.0000000000003830. Epub 2022 Nov 15     [PubMed PMID: 36730672]

Level 1 (high-level) evidence

[15]

Mokhlesi B, Masa JF, Brozek JL, Gurubhagavatula I, Murphy PB, Piper AJ, Tulaimat A, Afshar M, Balachandran JS, Dweik RA, Grunstein RR, Hart N, Kaw R, Lorenzi-Filho G, Pamidi S, Patel BK, Patil SP, Pépin JL, Soghier I, Tamae Kakazu M, Teodorescu M. Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2019 Aug 1:200(3):e6-e24. doi: 10.1164/rccm.201905-1071ST. Epub     [PubMed PMID: 31368798]

Level 1 (high-level) evidence

[16]

Schönhofer B, Sortor-Leger S. Equipment needs for noninvasive mechanical ventilation. The European respiratory journal. 2002 Oct:20(4):1029-36     [PubMed PMID: 12412700]


[17]

Toussaint M, Soudon P, Kinnear W. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy. Thorax. 2008 May:63(5):430-4     [PubMed PMID: 18057095]


[18]

MacIntyre NR. Physiologic Effects of Noninvasive Ventilation. Respiratory care. 2019 Jun:64(6):617-628. doi: 10.4187/respcare.06635. Epub     [PubMed PMID: 31110031]


[19]

Sahu N, Matthews P, Groner K, Papas MA, Megargel R. Observational Study on Safety of Prehospital BLS CPAP in Dyspnea. Prehospital and disaster medicine. 2017 Dec:32(6):610-614. doi: 10.1017/S1049023X17006677. Epub 2017 Jul 3     [PubMed PMID: 28669372]

Level 2 (mid-level) evidence

[20]

Kabi A, Kaeley N, Shankar T, Joshi S, Roul PK. COVID-19-Associated Pneumomediastinum and Pneumothorax: A Case Series. Cureus. 2021 Sep:13(9):e17715. doi: 10.7759/cureus.17715. Epub 2021 Sep 4     [PubMed PMID: 34650889]

Level 2 (mid-level) evidence

[21]

Ucgun I, Metintas M, Moral H, Alatas F, Yildirim H, Erginel S. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respiratory medicine. 2006 Jan:100(1):66-74     [PubMed PMID: 15890508]


[22]

Nielsen VM, Madsen J, Aasen A, Toft-Petersen AP, Lübcke K, Rasmussen BS, Christensen EF. Prehospital treatment with continuous positive airway pressure in patients with acute respiratory failure: a regional observational study. Scandinavian journal of trauma, resuscitation and emergency medicine. 2016 Oct 10:24(1):121     [PubMed PMID: 27724976]

Level 2 (mid-level) evidence